Atria1 natriuretic peptides (ANP) have recently been identified in both heart and CNS. These peptides possess potent natriuretic, diuretic, and vasorelaxant activities, and are all apparently derived from a single prohormone. Specific ANP binding sites have been characterized in the adrenal zona glomerulosa and kidney cortex, and one study reported ANP binding sites in the CNS. However, a detailed examination of the localization of ANP binding sites throughout the brain has not been reported. In this study, quantitative autoradiography was employed to examine the distribution of ANP receptors in the rat CNS. The binding of (3-'Z51-iodotyrosy128) rat ANP-28 to binding sites in the rat CNS was saturable, specific for ANP-related peptides, and displayed high affinity (& = 600 PM). When the relative concentrations of ANP binding sites were determined throughout the rat brain, the highest levels of ANP binding were localized to the circumventricular organs, including the area postrema and subfornical organ, and the olfactory apparatus. Moderate levels of ANP binding sites were present throughout the midbrain and brain stem, while low levels were found in the forebrain, diencephalon, basal ganglia, cortex, and cerebellum. The presence of ANP binding sites in the subfornical organ and the area postrema, regions considered to be outside the blood-brain barrier, suggests that peripheral ANP levels may regulate some aspects of CNS control of salt and water balance. The possible functions of ANP binding sites in other regions of the rat brain are not known, but, like many other peptides, ANP may act as a neurotransmitter or neuromodulator at these loci.
Atria1 natriuretic peptides (ANP) have recently been identified in both heart and CNS. These peptides possess potent natriuretic, diuretic, and vasorelaxant activities, and are all apparently derived from a single prohormone. Specific ANP binding sites have been characterized in the adrenal zona glomerulosa and kidney cortex, and one study reported ANP binding sites in the CNS. However, a detailed examination of the localization of ANP binding sites throughout the brain has not been reported. In this study, quantitative autoradiography was employed to examine the distribution of ANP receptors in the rat CNS. The binding of (3-'Z51-iodotyrosy128) rat ANP-28 to binding sites in the rat CNS was saturable, specific for ANP-related peptides, and displayed high affinity (& = 600 PM). When the relative concentrations of ANP binding sites were determined throughout the rat brain, the highest levels of ANP binding were localized to the circumventricular organs, including the area postrema and subfornical organ, and the olfactory apparatus. Moderate levels of ANP binding sites were present throughout the midbrain and brain stem, while low levels were found in the forebrain, diencephalon, basal ganglia, cortex, and cerebellum. The presence of ANP binding sites in the subfornical organ and the area postrema, regions considered to be outside the blood-brain barrier, suggests that peripheral ANP levels may regulate some aspects of CNS control of salt and water balance. The possible functions of ANP binding sites in other regions of the rat brain are not known, but, like many other peptides, ANP may act as a neurotransmitter or neuromodulator at these loci.
Much interest has been generated by the recent discovery of bioactive peptides within cardiac atria. These peptides, collectively referred to as atria1 natriuretic factor (ANF) or peptides (ANP), have been shown to exhibit natriuretic, diuretic, and vasorelaxant activities in several bioassay model systems (Currie et al., 1983; DeBold et al., 198 1) . ANP is also suggested to have an inhibitory effect on adrenal steroidogenesis (Matsuoka et al., 1985) . Although many bioactive peptides of varying size have been purified from atria1 tissue, all contain common amino acid sequences (Atlas et al., 1984; Currie et al., 1984) suggesting that these peptides may be shorter fragments of a large, common precursor. The isolation and characterization of both rat (Maki et al., 1984; Yamanka et al., 1984) and human (Oikawa et al., 1984) cloned atria1 cDNA encoding for ANP supports the hypothesis that all ANP-related peptides isolated to date can be generated from a common preprohormone.
ANP is one of many peptides originally discovered and characterized in peripheral organs and subsequently shown to exist in the CNS (Iversen, 1983; Krieger, 1983) . ANP-related peptides have been found in particularly high concentrations in the pons and hypothalamus, using both immunohistochemistry (Jacobowitz et al., 1985; Saper et al., 1985) and radioimmunoassay . In addition, different forms of ANP-related peptides are found in the rat hypothalamus, atria, and plasma (Glembotski et al., 1985; Mot-ii et al., 1985; . Therefore, ANP-related peptides may also be important physiological regulators of fluid balance through centrally mediated mechanisms.
ANP-related peptides are thought to produce their physiological effects by interacting with specific surface receptors on appropriate target tissues. Utilizing radioligand binding techniques, high-affinity (picomolar) binding sites for ANP have been identified and characterized on membranes derived from rabbit aorta, rabbit and rat kidney (Napier et al., 1984) and bovine adrenal cortex (Currie et al., 1984) . Specific binding sites with lower affinity (nanomolar) for ANP have also been shown to exist on cultured rat vascular smooth muscle cells (Hirata et al., 1984) . That these binding sites described by radioligand binding techniques are biologically relevant is suggested by 2 observations: (1) their affinities for ANP-related peptides are similar to the reported plasma concentrations of immunoreactive ANP and (2) the ability of various ANP analogs to inhibit the binding of labeled ANP to highaffinity membrane sites parallels the bioactive potencies of these analogs Napier et al., 1984) .
ANP binding sites in the rat brain have been demonstrated using autoradiography . The autoradiographic distribution of these binding sites was found to be unique compared to other peptide receptors, and binding was not inhibited by other peptide hormones or neurotransmitters. This report, however, did not contain quantitative data characterizing these central ANP binding sites. In the present report we utilize quantitative autoradiography to localize and characterize the ANP binding sites in the rat brain and adrenal gland.
Materials and Methods

Terminology
Since conflicting terminology has evolved in describing various ANPrelated peptides, the following standard abbreviations will be used throughout this paper: ANP-28, atria1 natriuretic peptide-or pro-ANP(99-126); AP III, atriopeptin III or pro-ANP( 103-l 26); AP I, atrio-peptin I or pro-ANP( 103-l 24); and ANP( 13-28), atria1 natriuretic peptide (13-28) or pro-ANP ( 11 l-l 26 
Tissue preparation
For regional localization by quantitative autoradiography, animals were decapitated and their brain tissue rapidly removed, mounted on cryostat chucks, and frozen in dry ice. Coronal sections (32 wrn) were cut at -18°C and thaw-mounted onto chromate/gelatin-subbed slides. Sections were then stored with desiccant at -20°C. Four consecutive sections at 500 pm intervals were mounted, 2 per slide, for total and nonspecific binding determinations.
For the biochemical characterization of Y-ANP-28 binding sites, 2 methods were employed. First, for analysis by gamma counting, olfactory bulbs or adrenal glands were obtained from freshly killed rats and quickly frozen on dry ice. This tissue was then thawed, minced, and homogenized to form a tissue mash. This mash was then placed into a 3 ml plastic syringe and frozen, and sections (32 rm) were cut and thawmounted (2 sections per slide). Second, for densitometric studies, olfactory bulb or adrenal tissue was mounted directly onto cryostat chucks and frozen; then, 32 pm sections were cut and thaw-mounted (2-4 sections per slide). All sections were stored desiccated at -20°C until needed.
Binding procedures
Slides were warmed to room temperature and preincubated for 10 min in slide jars filled with buffer (50 mM Tris-HCl, 150 mM NaCl, 5 mM MgCl,, 0.1% BSA, pH 7.4) at 25°C. After preincubation, sections were allowed to air-dry for at least 1 hr at 4°C. Slides were then incubated with 300 ~1 (whole-brain slices) or 200 pl (olfactory bulb and adrenal mash and slices) of 4°C buffer containing 5 &ml leupeptin, 10 PM bestatin, and varying concentrations of 12SI-ANP-28. These volumes were sufficient to cover completely both sections on a slide. Since the binding of 12+ANP-28 was shown to reach equilibrium after 90 min (not shown), the sections were incubated at 4°C for 2 hr; more than 95% of the iodinated lisand co-eluted with Y-ANP-28 standard on RP-HPLC (Glembotski-et al., 1985) after the incubation. They were then washed with 4°C buffer 4 times for 15 min each. Preliminary experiments established that little specific binding was lost by this procedure. and fewer washes after incubation resulted in a greater proportion of nonspecific binding. For gamma counting, the sections were wiued off the slides with Schleicher and Schuell no. 30 glass-fiber filter disks, placed in tubes, and counted in an LKB Minigamma gamma counter. For autoradiography, the slides were briefly dipped in 4°C distilled water to remove buffer salts and then rapidly dried on a 60-70°C slide drier.
Concentrations of lz51-ANP-28 employed were 50 PM for studies of reaional localization and for inhibition analysis. and from 35 to 1000 PM' for Scatchard analysis. For inhibition analysis, 10 concentrations of unlabeled ANP-related peptides spanning 5 orders of magnitude were included; other compounds were included at concentrations indicated in the text. Nonspecific binding was defined as the binding of lZSI-ANP-28 in the presence of 100 nM AP III. At 50 PM 12Y-ANP-28, specific binding in sections of tissue mash was 50-70% of total binding (1 OOO-2000 cpm).
Quantitative densitometry
Quantitative autoradiograms of lZSI-ANP-28 binding to tissue sections were prepared as described previously (Rainbow et al., 1982) . Sections were apposed to LRB Ultrofilm (LRB, Inc., Gaithersburg, MD), exposed at room temperature for 5 d, and developed.
Densitometric analysis ofautoradiograms was performed as described previously (Rainbow et al., 1982 (Rainbow et al., , 1984 Unnerstall et al., 1982) . Optical density values were converted into fmol/mg of protein using lZ51 standards prepared from brain mash mixed with known quantities of lz51-olMSH (Rainbow et al., 1984; Unnerstall et al., 1982) . Values for total and nonspecific binding of lZ51-ANP-28 for each brain region were obtained by averaging 4-8 readings of the 2 sections on each autoradiogram. Equal numbers of readings were taken bilaterally and averaged together. After autoradiography, the sections were stained with cresyl violet to allow the overlaying of the section and autoradiogram for localization of the binding to specific brain structures. For Scatchard and inhibition analyses, the plexiform layer of the olfactory bulb and the zona glomerulosa of the adrenal gland were analyzed utilizing the techniques described above. Inhibition analysis of lz51-ANP-28 binding to olfactory bulb and adrenal mash by gamma counting
When unlabeled ANP-related peptides were added to the incubation mixture, differing potencies of inhibition were obtained (Table 1) . AP III and ANP-28, comprising the 24 and 28 COOH-terminal amino acids of pro-ANP, respectively, inhibited the binding of 1251-ANP-28 by 50% with low nanomolar potency. At peptide concentrations higher than 100 nM, the competition curves were no longer monophasic, with an apparent low-affinity binding component. This low-affinity binding component has been reported previously for ANP binding Napier et al., 1984) and was not examined in the present study. AP I, which is COOH-terminally shortened by 2 amino acids as compared to AP III, inhibited the binding of Y-ANP-28 to olfactory bulb mash only at higher nanomolar concentrations. ANP( 13-28)-which does not contain both cysteine residues, and thus does not have the disulfide bond that is present in longer ANP-related peptides-failed to block the binding of the radiolabeled ligand even at a concentration of 10 PM. Inhibition of binding of 12sI-ANP-28 to adrenal mash by ANP-related peptides had a similar profile, although inhibition by AP I seemed to be more potent. Other peptide hormonesincluding TRH, DADLE, ACTH, aMSH, insulin, and P-endorphin (all at 1 &-were unable to compete for the binding of lZ51-ANP-28 in olfactory bulb mash. Propranolol, phentolamine, atropine (all at 10 @M), and carbachol(1 mM) were also ineffective. of olfactory bulb mash described above, while the higher B,,, value reflects the concentration of binding sites to only a specific layer of the olfactory bulb.
Densitometric quantitation of regional binding The distribution of atria1 natriuretic peptide binding sites in individual nuclei and subregions of rat brain was discrete and heterogeneous ( Fig. 1 ). Moderately high (1 .O-2.0 fmol/mg protein) to very high (2.0-4.0 fmol/mg protein) levels of 1251-ANP-28 binding sites were localized within the circumventricular organs and the olfactory apparatus (Table 2) . Moderate levels (0.5-1.0 fmol/mg protein) of ANP binding sites were present throughout the midbrain and brain stem. Low levels (<OS fmol/ mg protein) of lz51-ANP-28 binding sites were observed throughout the forebrain, diencephalon, basal ganglia, cortex, and cerebellum. Moderate to low levels of lZSI-ANP-28 binding sites were present in some white matter structures. Nonspecific binding was relatively homogeneous, ranging between 0.5 and 1.0 fmol/mg protein.
The accessory olfactory bulb contained the highest level of *ZSI-ANP-28 binding sites within the rat CNS (3.13 f 0.10 fmoll mg protein). The plexiform layers of the olfactory bulb also were very high in ANP binding sites (1.97 f 0.11 fmol/mg protein). This value suggests that, under the conditions used in this experiment, the fractional occupancy ofthese binding sites is about 6%, by comparison with the B,,, value of 3 1.9 fmoVmg protein (see above). Other layers of the olfactory bulb (granular, glomerulosa) contained moderate levels of ANP binding sites. Within white matter regions of the olfactory apparatus, the lateral olfactory tract possessed moderately high levels of ANP binding sites throughout its rostrocaudal extent, while the olfactory nerve contained only moderate levels of ANP binding sites.
The circumventricular organs were noted to have a highly heterogeneous distribution of ANP binding sites. The area postrema contained the highest level of ANP binding sites (2.27 f 0.55 fmol/mg protein), while the subfomical organ contained a moderately high level (1.5 1 + 0.26 fmol/mg protein). The median eminence possessed a moderate level of ANP binding sites, whereas the subcommissural organ and the pineal gland contained low levels of lZ51-ANP-28 binding.
Within the midbrain and brain stem, the interpeduncular nucleus contained the highest level of ANP binding sites (0.86 +-0.08 fmol/mg protein). The substantia nigra, central gray, and both colliculi contained low to moderate levels of ANP binding sites. Individual nuclei of the reticular formation (lateral, medullary, paragigantocellular) possessed low to moderate levels of ANP binding sites, as did the subregions of the raphe and the superior and inferior olives. All motor and sensory nuclei of the cranial nerves examined contained low levels of '251-ANP-28.
Within the diencephalon, the highest levels of ANP binding sites were localized within the habenular nuclei (1.05 + 0.14 fmol/mg protein). Most other thalamic nuclei contained low to moderate levels of ANP binding sites. In comparison to the thalamus, the nuclei and subregions of the hypothalamus contained predominantly low levels of ANP binding sites. The arcuate, paraventricular, ventromedial, and posterior nuclei and the preoptic, anterior, and lateral areas all contained between 0.3 and 0.4 fmol/mg protein of '*51-ANP-28 binding sites. The limbic forebrain contained low levels of ANP binding sites. Individual nuclei of the amygdala were homogeneously labeled with low levels of lZ51-ANP-28. Although the ventral hippocampal commissure had moderate levels of ANP binding sites (0.70 k 0.10 fmol/mg protein), all subfields of the hippocampus, as well as the dentate gyms and subiculum, contained low levels. The septum, olfactory tubercle, and bed nucleus of the stria terminalis also possessed low levels of specific binding of '=I-ANP-28
The basal ganglia (accumbens nucleus, ventral palladium, and globus pallidus) all possessed less than 0.4 fmol/mg protein of ANP binding sites. The caudate was homogeneously labeled by *251-ANP-28 at a low level (0.12 -t 0.02 fmol/mg protein). Similarly, the cerebellum was homogeneously labeled (0.28 + 0.03 fmol/mg protein) in low density, with no difference observed between the molecular and granular layers.
The cerebral cortex contained low levels of lZ51-ANP-28 binding sites. Striate cortex was the only region of cortex that contained a moderate level of ANP binding sites (0.52 ~fr 0.08 fmol/ mg protein). All other regions of cortex examined (cingulate, frontal, olfactory) possessed low levels (~0.4 fmol/mg protein) of ANP binding sites. No variation between individual layers of the cerebral cortex was observed.
Discussion
Utilizing the technique of quantitative autoradiography, this report describes the discrete and heterogeneous distribution of ANP receptors throughout the rat brain (Fig. 1) . The highest levels of ANP receptors were localized to the circumventricular organs and the olfactory apparatus (Table 2 ). Moderate levels of ANP receptors were found in the midbrain and brain stem, while low levels were localized throughout the forebrain, diencephalon, basal ganglia, cortex, and cerebellum.
It is particularly interesting that the distribution of ANP receptors in the CNS includes the subfomical organ and area postrema. Utilizing behavioral and physiological methods, these structures have been determined to be part of a neural network mediating water and sodium balance (Hyde and Miselis, 1984; Miselis, 198 1, 1982) . In addition, the subfomical organ and the area postrema have been shown to possess high levels of angiotensin II receptors (Mendelsohn et al., 1984) and sites of angiotensin II action on the CNS. Lesions of the subfomical organ in rat abolish the dipsogenic response to peripheral angiotensin II administration (Simpson, 198 l) , while area postrema lesions result in an exaggerated drinking response to this peptide (Edwards and Ritter, 1982) . Thus, the effect of angiotensin II binding to the area postrema appears to antagonize the dipsogenic mechanism of angiotensin II reception at the subfomical organ. This phenomenon may also occur in the ANP system, since lesions of the area postrema evoke natriuresis, while lesions of the anteroventral third ventricle region (AV3V), which contains many afferent and efferent connections with the subfomical organ, elicit hypematremia (Buggy and Johnson, 1977; Hyde and Miselis, 1984) . Such a system would constitute another source of feedback control by cardiac atria of the neuroendocrine regulation of extracellular volume, in addition to the modulation of ADH secretion by atria1 stretch receptors (Ledsome, 1985) .
In contrast to the distribution of ANP receptors in the rat CNS, immunohistochemical studies have revealed relatively high (5) 0.47 I! 0.13 Principal sensory nucleus (5) 0.48 + 0.08 Facial nucleus (7) 0.53 + 0.10 Vestibular nucleus (8) Brain sections (32 pm) were cut at 500 pm intervals corresponding to coronal levels of the atlas of Paxinos and Watson (1982) . Serially cut sections at each level were used for determination of total and nonspecific binding. Nonspecific binding was subtracted from each structure at each level. Values are means + SE from readings taken from 4 rat brains. levels of ANP-related peptides in the preoptic area and the pontine tegmentum (Saper et al., 1985) sites of low levels of ANP receptors. This disparity in localization between a peptide and its receptor has been observed previously, and several explanations have been proposed (Kuhar and Unnerstall, 1985) . However, the existence of ANP-related peptides in the AV3V region of the preoptic area is especially intriguing, since fibers from the subfornical organ extend directly to the AV3V (Miselis, 1981) . The subfornical organ also has afferent connections to the paraventricular nucleus and lateral area of the hypothala-
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Gibson et al. Vol. 6, No. 7, Jul. 1986 mus, the bed nucleus of the stria terminalis, and the perifomical region (Miselis, 1981; Weiss et al., 1984) , all areas shown to possess neurons that contain ANP immunoreactivity (Saper et al., 1985) . In addition, a major projection from the area postrema extends to the lateral parabranchial nucleus (Shapiro and Miselis, 1985) , which has been shown to contain fibers from the AV3V that contain ANP-immunoreactive material (Saper et al., 1985) .
Thus, it is apparent that numerous connections exist between ANP receptor-containing and ANP-related peptide-containing structures. Also, fibers from the subfomical organ extend to the organum vasculosum of the lamina terminalis (OVLT), a structure postulated to be directly involved in peripheral ANP feedback control of CNS fluid balance regulation (Saper et al., 1985) . Although it is difficult to visualize the OVLT in coronal sections, in several sections we observed moderate to moderately high levels of ANP binding sites in the OVLT region. Thus, the OVLT itself might be included in the group of circumventricular organs that contain ANP receptors.
Another region containing high levels of ANP receptors, the olfactory apparatus, has few known functions other than olfaction. However, the olfactory bulb contains numerous neuropeptides and peptide receptors. For example, insulin, luteinizing hormone-releasing hormone, substance P, Met-enkephalin, TRH, somatostatin, and angiotensin II are all highly concentrated in the olfactory bulb (Bogen et al., 1982; Brownstein et al., 1975 Brownstein et al., , 1976 Havrankova et al., 1978; Jennes and Stumpf, 1980; Kreider et al., 1981; Lind et al., 1985) . Peptide receptors, such as those for TRH and cholecystokinin, are also present in the olfactory bulb in high levels (Gaudreau et al., 1983; Manaker et al., 1985; Van Dijk et al., 1984; Zarbin et al., 1983a) . This concentration of peptides and peptide receptors may indicate that the olfactory apparatus utilizes a rich variety of peptides in the neurochemistry of olfaction, or it could suggest that the olfactory bulb may have other (as yet undiscovered) functions.
ANP binding was also found in the lateral region of the medial habenular nucleus of the thalamus and the interpeduncular nucleus of the midbrain. Interestingly, these 2 nuclei are connected by the fasciculus retroflexus, which also contains ANP binding sites (Fig. 1) . The function of ANP receptors in these areas is not known, but the presence of ANP binding in all 3 structures suggests that the habenular and interpeduncular nuclei may be part of an integrated network, functionally as well as structurally.
It has been discovered that different forms of ANP-related peptides are present in various tissues. In the atria, ANP-immunoreactive material has been found predominately in a, lo-15 kilodalton (kDa) form, while smaller forms have been localized to the plasma (3 kDa) and hypothalamus (1.5 kDa) (Glembotski et al., 1985; Morii et al., 1985; Tanaka et al., 1984) . Thus, cardiac-derived ANP-related peptides in the plasma (the 3 kDa form) may act on the CNS through receptors in the subfomical organ and area postrema (both circumventricular organs outside the blood-brain barrier), perhaps similarly to the way that angiotensin II acts on these structures (Edwards and Ritter, 1982; Simpson, 1981) . In contrast, the different forms of ANP found within the brain (such as the hypothalamus) may interact with receptors found in the olfactory apparatus and hindbrain, much like classical neurotransmitters or neuromodulators.
Given the relative lack of data on the physiological effects of ANP in the CNS, we cannot now rule out the possibility that t these binding sites in the CNS are merely acceptors for ANP, and not ANP receptors . It is even possible that these binding sites may not be on neurons, but on glia or capillaries, although the pattern of binding, for example, in the olfactory bulb would argue against this hypothesis. In addition, one recent study did demonstrate that basal release of arginine vasopressin from the neural lobe of the pituitary was decreased when 2 nmol AP III were injected into the third ventricle of conscious male rats (Samson, 1985) . This would indicate that ANP receptors are indeed involved in brain function. Further electrophysiological and microinjection studies are needed to demonstrate that these binding sites are biologically relevant receptors that mediate the actions of ANP on the CNS.
It has been established that, in some bioassay systems, the COOH-terminal tyrosine of Pro-ANP-derived peptides is important to the bioactivity of these peptides (Garcia et al., 1985) . In the present study, (3-12SI-iodotyrosy128) rat ANP-28 was used as the radiolabeled ligand. The presence of the large iodine atom attached to the COOH-terminal tyrosine might have resulted in a different affinity for the receptor, as opposed to the native peptide, as well as a different pharmacological profile in competition experiments. Since '*'I-ANP was shown to have equal potency to noniodinated ANP in the rat and rabbit aorta bioassay (Napier et al., 1984) and the IC,, values obtained in the present study using unlabeled ligand are similar to the lZSI-ANP-28 K, values, the modification of this tyrosine apparently does not radically change the properties of the peptide as a ligand. However, the Kd values obtained in the present study do seem to differ from those in some other studies. Napier et al. (1984) obtained K,, values of 50 PM for ANP-28 binding to partially purified kidney membranes, while our higher Kd and IC,, values were obtained by binding to sections of olfactory bulb and adrenal mash and tissue sections. Significant differences in Kd values have been obtained previously in other systems when these 2 different binding protocols have been compared. For example, when binding of quinuclidinyl benzilate to muscat-uric receptors was examined, K, values of 14, 270, and 500 PM were obtained in experiments using prepared membranes and 10 and 32 pm sections, respectively (Luthin and Wolfe, 1984; Rainbow et al., 1982; Wamsley et al., 198 1) . Thus, it appears that the inability of the ligand to penetrate into tissue sections may be implicated in the higher Kd values obtained as tissue thickness increases.
In the present study, specific binding to white matter structures was observed, and this binding appeared to be discrete and heterogeneous as well. For example, while the corpus callosum and olfactory apparatus white matter contained moderate to moderately high levels of ANP receptors, the cranial nerves examined and the cerebellar and cerebral peduncles contained much lower levels. In addition, within the corpus callosum itself, the medial corpus callosum contained higher levels than did the more lateral regions. Thus, it seems that these binding sites within white matter are not simply nonspecific binding, but represent actual specific binding sites. While the function of ANP binding sites within white matter is not known, they could represent receptors in transit to distal regions, as reported for other peptides and classical neurotransmitters (Laduron, 1980; Young et al., 1980; Zarbin et al., 1981 Zarbin et al., , 1983b . For example, the receptors present in the lateral olfactory tracts could be in transit from or to the olfactory bulb, which contains high levels of ANP receptors. It is possible that these binding sites might not be actual receptors, and may be of lower affinity. Indeed, layer of olfactory bulb; CR, granular layer of olfactory bulb; ON, olfactory nerve. B, Level 16: SFO, subfomical organ; CC, corpus callosum; VHC, ventral hippocampal commissure; CD, caudate. C, Level 21: HB, habenular nucleus of the thalamus; CC, corpus callosum; CA3, level CA3 of the hippocampus; FR, fasciculus retroflexus. D. Level 42: AP, area postrema; CB, cerebellum; MR, medullary reticular formation. E, Adrenal section: GM, zona glomerulosa; FS, zona fasciculata; RT, zona reticulata; AM, adrenal medulla. Quirion et al. (1984) found nondisplaceable binding in white matter, although a different peptide was used to determine nonspecific binding than in the present study.
In conclusion, binding sites for ANP have been localized to both peripheral and CNS regions. The localization of specific binding sites to the circumventricular organs suggests that ANPrelated peptides may play a key role in integrating the abilities of the nervous and endocrine systems to regulate fluid and electrolyte balance. Further characterization of the factors responsible for the regulation of both peripheral and central ANP and ANP receptor levels will facilitate an understanding of the role of ANP in the heart and CNS as an important regulator of fluid balance.
